Paka Pulmonary Pharmaceuticals Inc Brooklyn, NY - 11223

Paka Pulmonary Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Brooklyn, NY .

Paka Pulmonary Pharmaceuticals Inc was established in 0, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Frank Guarnieri at the company’s single location by writing to 1742 West 11th St, Brooklyn, New York NY 11223 or by phoning (718) 887-4206. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Paka Pulmonary Pharmaceuticals Inc
Contact Person: Frank Guarnieri
Address: 1742 West 11th St, Brooklyn, New York 11223
Phone Number: (718) 887-4206
Annual Revenue (USD): $50.000 to $99.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Paka Pulmonary Pharmaceuticals Inc was started in 0 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Frank Guarnieri for inquiries that concern Paka Pulmonary Pharmaceuticals Inc by calling the company number (718) 887-4206, as your correspondence is most welcome. Additionally, the physical location of the single location of Paka Pulmonary Pharmaceuticals Inc can be found at the coordinates as well as the street address 1742 West 11th St in Brooklyn, New York 11223.

For its online presence, you may visit Paka Pulmonary Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.